MediFind

Find a Doctor

James J. Harding

Msk Harrison
Oncology, Hematology, Internal Medicine
Male
Practicing approx. 13 years

Bio


James Harding is an Oncologist and an Internal Medicine specialist in New York, New York. He has been an author on 71 peer reviewed articles and participated in 1 clinical trials in the past 15 years. Dr. Harding's top three areas of expertise are Liver Cancer, Pancreatic Cancer, and Fibrolamellar Carcinoma. He is licensed to treat patients in NY.

Contact

1275 York Ave
New York, NY 10065, US

Latest Research


Latest Advance
Study
  • Condition: Advanced Cancer
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Ramucirumab in Combination with Emibetuzumab
  • Number of Patients: 97
  • Published —
This study reported the results of the phase Ib/II study of ramucirumab, a monoclonal anti-VEGFR-2 antibody, plus the anti-MET mAb emibetuzumab in the treatment of advanced cancer.
Latest Advance
Study
  • Condition: Liver Carcinoma
  • Journal: AJR. American journal of roentgenology
  • Treatment Used: Aspirin after Transarterial Embolization
  • Number of Patients: 304
  • Published —
This study tested the safety and efficacy of using aspirin after a transarterial embolization to treat patients with liver carcinoma.
Latest Advance
Study
  • Condition: Gallbladder Carcinoma (GBCA)
  • Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
  • Treatment Used: Surgical Management
  • Number of Patients: 675
  • Published —
This study described differences in presentation, surgery, chemotherapy strategy, and survival for patients with gallbladder cancer (GBCA) over two decades at a tertiary referral center.
Latest Advance
Study
  • Condition: Advanced Pancreatic Cancer
  • Journal: BMC cancer
  • Treatment Used: Nanoliposomal Irinotecan with Fluorouracil (Nal-IRI?+?5-FU/LV)
  • Number of Patients: 56
  • Published —
This study evaluated the safety and effectiveness of nanoliposomal irinotecan with fluorouracil/leucovorin (nal-IRI?+?5-FU/LV) in patients with advanced pancreatic cancer.

Contact

1275 York Ave
New York, NY 10065, US

Affiliations

  • Memorial Hospital For Cancer And Allied Diseases

Credentials

  • Graduate InstitutionAlbert Einstein College Of Medicine Of Yeshiva University
    2007
  • Licenses
    Internal Medicine in NY
  • Board Certifications
    Medical Oncology

Insurance

Contact them to find out if they accept your insurance plan.